Luigi Boltri, PH.D., senior director, Pharmaceutical Sciences, Adare Pharma Solutions, addresses the challenges of paediatric formulations, and how specialised technology platforms can provide ease of application and improve patient outcomes.
Key insights:
- Texture and taste have an impact on the acceptability of a drug formulation, particularly for paediatric patients; the most acceptable textures are a combination of mild flavours and smooth textures.
- Adare's expertise in paediatric formulations helps them address complexities that are challenging for companies new to pursuing patient-centered development.
- Adare’s Parvulet dosage form, which approximates the texture of easy-to-swallow soft foods, can be an important aspect of a paediatric formulation.
Paediatric populations represent the most diverse patient groups in all of medicine. Factors such as individual preferences, physiology, and dosage considerations all serve to complicate drug formulation aimed at paediatric care. Drug formulation for children has become increasingly important as the healthcare field recognises the huge impact that strict patient adherence can have on a treatment’s efficacy.